Effect of sensor-augmented pump treatment vs. multiple daily injections on albuminuria: a 1 year randomized study.
CONCLUSION: SAP treatment reduced UACR in a randomized controlled trial in type 1 diabetes patients with a history of albuminuria on stable RAS-inhibition. Significance was reached after adjustment. SAP treatment reduced HbA1c and glucose variability (calculated as SD).
PMID: 26390102 [PubMed - as supplied by publisher]
Source: Diabetes Metab - Category: Endocrinology Authors: Rosenlund S, Willum Hansen T, Rossing P, Andersen S Tags: J Clin Endocrinol Metab Source Type: research